Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Thursday, March 28, 2024 · 699,419,870 Articles · 3+ Million Readers

Neuro Kinetics, Inc. Releases Enhanced VEST™ & I-Portal® Software

Green Head/Eye Icon with Green and Blue Verbiage

VEST™ operating and neurotologic analysis software screenshot.

VEST™ 8.2 operating and neurotologic analysis software offers a visual and easy-to-use interface.

All I-Portal® system tests are built into one software platform, eliminating the need to learn multiple software.

I-Portal® 6.2, the VEST™ 8.2 companion, captures and tracks precise, high-speed digital images of the eye.

New Features Improve Efficiencies and the User Experience on All NKI I-Portal® Devices

Studies increasingly show the value of OVRT-C (Oculomotor, Vestibular, Reaction Time, and Cognitive) testing using NKI’s I-Portal systems.”
— Susan Zelicoff, Vice President of Marketing, Neuro Kinetics, Inc.
PITTSBURGH, PENNSYLVANIA, UNITED STATES, June 18, 2019 /EINPresswire.com/ -- Neuro Kinetics, Inc. Releases Enhanced VEST™ & I-Portal® Software
New Features Improve Efficiencies and the User Experience on All NKI I-Portal® Devices

Neuro Kinetics, Inc. (NKI) announced today that they have released VEST™ 8.2 and I-Portal® 6.2 software upgrades, both of which include numerous new features for users of I-Portal® NOTC (Neurotologic Test Center), I-Portal® VNG, and I-PAS™ (I-Portal® Portable Assessment System), NKI’s proprietary clinical eye tracking devices. I-Portal® captures eye-tracking video and eye position data, and works symbiotically with VEST™, which helps administer tests (e.g., presents visual stimuli, analyzes data, provides tools for inspecting and managing results, and stores patient and test information in an organized, accessible database). The new features improve efficiencies and the user experience on all NKI I-Portal® devices.
VEST™ 8.2 and I-Portal® Enhancements include:

• An auto-run setting which allows a clinician to program sequential tests and eliminate downtime between blocked tests;
• Adjustable settings for optional patient and operator voice prompts;
• More efficient video saving and storage features;
• An entirely new electrooculography (EOG) utility analysis and user interface;
• Custom Test now displays motion sensor feedback collected by the I-Portal® Falcon™ video oculography. The feedback results for both head position and velocity are viewed against the complementary eye position or velocity data in the analysis window, which not only elevates the overall quality of data obtained but also improves the efficiency of NKI’s I-Portal® systems.

NKI has begun shipping VEST™ 8.2 and I-Portal® 6.2 on new products, as well as upgrading customers’ existing systems.

Susan Zelicoff, Vice President of Marketing, explained, “NKI is constantly improving its VEST™ and I-Portal® software and analytics, because they are the foundations of our products.”

“It’s an opportune time for us to offer these enhancements, given the many reasons customers are looking to upgrade their existing systems or buy anew, she continued. “One reason is the steady obsolescence of FireWire technology. Second, Microsoft Corp. has announced it will no longer support Windows 7 Operating Systems in 2020. Third, and maybe most importantly, studies increasingly show the value of OVRT-C (Oculomotor, Vestibular, Reaction Time, and Cognitive) testing using NKI’s I-Portal systems.”

In a world of constant improvements, NKI’s next software release is well underway and is expected later this summer, concurrent with several new, game-changing tests. Pressure to release these new tests is in response to the high demand for additional measurement tools to help healthcare providers who treat patients with mTBI (mild traumatic brain injury) or concussion. NKI stands ready with solutions that continue to offer exceptional clinical utility and great value.

ABOUT NKI
Neuro Kinetics, Inc. (NKI) is the leader in clinical eye tracking and non-invasive neuro-functional diagnostics and monitoring, offering technology that identifies abnormal eye responses connected to more than 200 diseases and medical conditions. NKI’s FDA-cleared I-Portal® devices are sold to physical therapists, audiologists, ENTs, neurotologists, neuro-chiropractors, neuro-ophthalmologists, and neurologists around the globe. The company's cleared diagnostic platforms include the I-PAS® (I-Portal® Portable Assessment System), I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG, (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training, and support services. To learn more, please refer to the "Resources" page on NKI’s website (www.neuro-kinetics.com) for research on the role of I-Portal® in various concussion studies.

Susan Zelicoff
Neuro Kinetics, Inc.
+1 412-963-6649
email us here

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release